Adie Viljoen
-
- Diabetes Treatment and Management 31
- Diabetes, Cardiovascular Risks, and Lipoproteins 24
- Diabetes Management and Research 13
- Pharmacology top 1%
- Pharmacology and Obesity Treatment 9
- Nephrology top 5%
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 27
- Physiology top 5%
-
- Metabolism, Diabetes, and Cancer 22
-
- Health Systems, Economic Evaluations, Quality of Life 8
-
- Lipid metabolism and disorders 7
Adie Viljoen
93 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Endocrinology, Diabetes and Metabolism 1.9k
- Pharmacology 724
- Nephrology 191
- Surgery 873
- Physiology 507
Countries citing papers authored by Adie Viljoen
This map shows the geographic impact of Adie Viljoen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adie Viljoen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adie Viljoen more than expected).
Fields of papers citing papers by Adie Viljoen
This network shows the impact of papers produced by Adie Viljoen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adie Viljoen. The network helps show where Adie Viljoen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adie Viljoen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 0 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 9 | |
| 6 | 2022 | 7 | |
| 7 | 2021 | 21 | |
| 8 | 2021 | 17 | |
| 9 | 2020 | 13 | |
| 10 | 2019 | 1 | |
| 11 | 2019 | 37 | |
| 12 | 2018 | 2 | |
| 13 | 2016 | 45 | |
| 14 | 2015 | 8 | |
| 15 | 2012 | 29 | |
| 16 | 2012 | 7 | |
| 17 | 2012 | 29 | |
| 18 | 2011 | 1 | |
| 19 | 2011 | 2 | |
| 20 | 2007 | 13 |
About Adie Viljoen
Adie Viljoen is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Family Practice, having authored 98 papers that have together received 3.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (31 papers), Lipoproteins and Cardiovascular Health (27 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (24 papers), Metabolism, Diabetes, and Cancer (22 papers), Diabetes Management and Research (13 papers), Pharmacology and Obesity Treatment (9 papers), Health Systems, Economic Evaluations, Quality of Life (8 papers) and Lipid metabolism and disorders (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.9k citations), Pharmacology (724 citations) and Nephrology (191 citations). Adie Viljoen has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ildiko Lingvay, Anthony S. Wierzbicki, Richard E. Pratley, Vanita R. Aroda, J Lüdemann, Andrea Navarria, Catharine M. Sturgeon, Sue D. Pedersen, Iichiro Shimomura and Thomas A. Wadden.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.